best glp-1 drug 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Top 50 Best-Selling Drugs to
Description
Abdi AM, Pasiou E, Konstantopoulos P, Driva TS, Kontos A, Papagianni E, et al
Neurobiol Aging 8(3):225232
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes
[DOI] [PubMed] [Google Scholar] 554.Khalilnezhad A., Taskiran D
2020 Mar 9;11(1):1272
GLP-1 rescued gestational diabetes mellitus-induced suppression of fetal thalamus development
